At a glance overview of the worldwide impact of depression, focusing on various aspects such as its prevalence, economic burden, treatment challenges, and emerging research areas.
The infographic shows a 27% increase in depression cases due to COVID-19, affecting 280 million people worldwide. The economic impact in the U.S. reached $326 billion in 2018, a 35% increase since 2010. About 30% of those with Major Depressive Disorder (MDD) are resistant to standard treatments. There’s growing interest in psychedelic research for treating depression, focusing on their ability to activate brain receptors and promote neuroplasticity.
Related content
Patients with bipolar disorder and comorbidities are typically more complex cases than those without medical or psychiatric comorbidities
Factors associated with mixed features includes unemployment among others
In this video, Professors Lakshmi Yatham, MD., and Christoph Correll, MD. discuss the challenges of differentiating bipolar disorder.